Abstract
Anxiety is a common neuropsychiatric manifestation of PD that has a Significant impact on disease-related QOL. There is a remarkable paucity of organized data on the choice of pharmacological management of anxiety in PD. Well-designed studies are necessary. However, based on clinical experience, the agents that are effective in management of the primary anxiety disorders also appear to be efficacious in PD-related anxiety.
Original language | English (US) |
---|---|
Title of host publication | Parkinson's Disease and Nonmotor Dysfunction |
Subtitle of host publication | Second Edition |
Publisher | Humana Press Inc |
Pages | 17-29 |
Number of pages | 13 |
ISBN (Electronic) | 9781607614296 |
ISBN (Print) | 9781607614289 |
DOIs | |
State | Published - Jan 1 2013 |
Keywords
- Agoraphobia
- Anxiety disorders
- Anxiety disorders in PD
- Anxiety status inventory
- Beck anxiety inventory
- Hamilton anxiety rating scale
- Hospital anxiety and depression scale
- Spielberger state trait anxiety inventory
- Zung self-rating anxiety scale
ASJC Scopus subject areas
- Medicine(all)